Donga Ejiao announced on the evening of August 30 that, based on its own development strategy, business situation and financial situation, the company formulated a “Double Improvement of Quality and Return” action plan. Specific measures include deepening the main business of the Ejiao industry and building a new pattern of nourishing health; consolidating the foundation of corporate governance and efficiently improving the level of standardized operation; gathering momentum for innovation and development to gather new quality productivity; disclosing accurate compliance information and actively smoothing capital market communication channels; and adhering to investors' focus to continuously enhance investors' sense of attainment. In the future, the company will comprehensively improve the operating quality of listed companies, actively implement the “Double Improvement of Quality and Return” action plan, focus on building a “two-wheel drive” market value management model that strengthens communication and value transmission, and is committed to becoming the best practitioner of market value management for listed Chinese medicine companies.

Donga Ejiao announced on the evening of August 30 that, based on its own development strategy, business situation and financial situation, the company formulated a “Double Improvement of Quality and Return” action plan. Specific measures include deepening the main business of the Ejiao industry and building a new pattern of nourishing health; consolidating the foundation of corporate governance and efficiently improving the level of standardized operation; gathering momentum for innovation and development to gather new quality productivity; disclosing accurate compliance information and actively smoothing capital market communication channels; and adhering to investors' focus to continuously enhance investors' sense of attainment. In the future, the company will comprehensively improve the operating quality of listed companies, actively implement the “Double Improvement of Quality and Return” action plan, focus on building a “two-wheel drive” market value management model that strengthens communication and value transmission, and is committed to becoming the best practitioner of market value management for listed Chinese medicine companies.